This inventor holds 1 USPTO granted patent. Top assignee: Purdue Research Foundation. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Sarah Emma St John
Introduction
Sarah Emma St John is a prominent inventor based in West Lafayette, Indiana. She has made significant strides in the field of medical research, particularly in the development of treatments for coronavirus infections. Her work is crucial in addressing the challenges posed by zoonotic disease outbreaks.
Latest Patents
St John holds a patent for "Broad-spectrum non-covalent coronavirus protease inhibitors." This invention pertains to materials and methods for the treatment of patients with coronavirus infection and the control of zoonotic disease outbreaks using broad-spectrum non-covalent coronavirus protease inhibitors. This patent highlights her innovative approach to tackling pressing health issues.
Career Highlights
St John is affiliated with the Purdue Research Foundation, where she contributes her expertise to various research initiatives. Her dedication to advancing medical science is evident in her focused research and innovative solutions.
Collaborations
One of her notable collaborators is Andrew Mesecar, with whom she has worked on various projects aimed at enhancing the understanding and treatment of viral infections.
Conclusion
Sarah Emma St John's contributions to the field of medical research, particularly through her patent on coronavirus protease inhibitors, underscore her role as an influential inventor. Her work continues to pave the way for advancements in the treatment of infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile